Background Registry data add important information to randomized controlled trials (RCT)
on real‐life aspects of implantable cardioverter‐defibrillator (ICD) patients with and without …

CRT‐P versus CRT‐D Outcomes Background Cardiac resynchronization therapy (CRT) is
commonly used to manage heart failure, yet published guidelines do not distinguish …

Cardiac resynchronization therapy (CRT) is a treatment of proven efficacy for selected
patients with heart failure and associated conduction disturbances. The increasing financial …

Objectives Cardiac resynchronization therapy with a biventricular pacemaker (CRT-P) is an
effective treatment for dyssynchronous heart failure (DHF). Adding an implantable …

Aims The additional benefit of a defibrillator in cardiac resynchronization therapy (CRT)
patients is a matter of debate. Cause-of-death analysis in a CRT population has been …

Aims In candidates for cardiac resynchronization therapy (CRT), the choice between
pacemaker (CRT-P) and defibrillator (CRT-D) implantation is still debated. We compared the …

The field of electrical device therapy has benefited from two basically independent lines of
investigation demonstrating mortal benefit from either cardiac resynchronization therapy …

Objective In patients indicated for cardiac resynchronisation therapy (CRT), the choice
between a CRT-pacemaker (CRT-P) versus defibrillator (CRT-D) remains controversial and …

Objective Responders to cardiac resynchronisation therapy whose device has a defibrillator
component and who do not receive a therapy in the lifetime of the first generator have a very …

Aims Cardiac resynchronization therapy (CRT) for chronic heart failure with left ventricular
systolic dysfunction (LVSD) consistently improves survival against optimal medical therapy …